Juniper Biosciences LLC

About Juniper Biosciences LLC

Juniper Biosciences is dedicated to revolutionizing healthcare through innovative radiopharmaceuticals. Their mission is to improve patient access to novel therapeutic and diagnostic medicines, addressing unmet needs in cancer and other diseases while maintaining high standards of quality. Their vision is to be a leader in radiopharmaceutical innovation.

Products & Services

Radiopharmaceutical Agents:A pipeline of radiopharmaceutical agents for multiple disease states, including clinically proven solutions and novel theranostics for diagnosis and treatment with minimal side effects.

Specialties

Radiopharmaceuticals Nuclear Medicine Cancer Diagnostics and Treatment Theranostics

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed T: - FT: Seed	A: 40000000 MR: - FA: $40 million FAN: 40000000	D: 2025-12-01 FD: 2025-12-01	3 investors

Seed Latest

2025-12-01

$40.0M

3 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Alex Agnoletto

Chief Executive Officer, Co-Founder & Board Member

LinkedIn (Pro only)

D

Dr. Kyle Hoffmann

Director of Manufacturing, Co-Founder

D

Dr. Indranil Nandi

Chief Operating Officer, Co-Founder & Board Member

D

Dr. Serge Lyashchenko

Advisor, Co-Founder, Board Member

S

Sharon Roded

Advisor, Co-Founder, Board Member

P

Pietro Bubba Bello

Advisor, Board Member

View 3 more team members with Pro

Unlock Full Team Directory

Recent News